Outcomes and complication rates of different bone grafting modalities in long bone fracture nonunions: A retrospective cohort study in 182 patients

Journal of Orthopaedic Surgery and Research

Volumn 8, Issue 1, 2013, Pages

  Flierl, Michael A ^a   Smith, Wade R ^b   Mauffrey, Cyril ^a   Irgit, Kaan ^b   Williams, Allison E ^c   Ross, Erin ^a   Peacher, Gabrielle ^a   Hak, David J ^a   Stahel, Philip F ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b GEISINGER MEDICAL CENTER   (United States)

^c Bay Pines VA Healthcare System   (United States)

Author keywords

Allograft; Autograft; Bone morphogenetic protein; Fracture nonunion

Indexed keywords

BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT PROTEIN;

ADOLESCENT; ADULT; AGED; ALLOTRANSPLANTATION; ARTICLE; AUTOTRANSPLANTATION; BONE TRANSPLANTATION; FEMALE; FEMUR FRACTURE; FRACTURE HEALING; FRACTURE NONUNION; HUMAN; HUMERUS FRACTURE; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; POSTOPERATIVE PERIOD; RADIOGRAPHY; REOPERATION; RETROSPECTIVE STUDY; TIBIA FRACTURE; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE MORPHOGENETIC PROTEIN 2; BONE TRANSPLANTATION; FEMALE; FEMORAL FRACTURES; FRACTURE HEALING; FRACTURES, UNUNITED; HUMANS; HUMERAL FRACTURES; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RECOMBINANT PROTEINS; REOPERATION; RETROSPECTIVE STUDIES; TIBIAL FRACTURES; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84883626117     PISSN: None     EISSN: 1749799X     Source Type: Journal    
DOI: 10.1186/1749-799X-8-33     Document Type: Article

References (44)

1. Marsh D. Concepts of fracture union, delayed union, and nonunion. Clin Orthop Relat Res 1998, 355:S22-S30.
2. Hak DJ. Management of aseptic tibial nonunion. J Am Acad Orthop Surg 2011, 19(9):563-573.
3. Tzioupis C, Giannoudis PV. Prevalence of long-bone non-unions. Injury 2007, 38(Suppl 2):S3-S9.
4. Lynch JR, Taitsman LA, Barei DP, Nork SE. Femoral nonunion: risk factors and treatment options. J Am Acad Orthop Surg 2008, 16(2):88-97.
5. Kanakaris NK, Giannoudis PV. The health economics of the treatment of long-bone non-unions. Injury 2007, 38(Suppl 2):S77-S84.
6. Oakley MJ, Smith WR, Morgan SJ, Ziran NM, Ziran BH. Repetitive posterior iliac crest autograft harvest resulting in an unstable pelvic fracture and infected nonunion: case report and review of the literature. Patient Saf Surg 2007, 1(1):6. 10.1186/1754-9493-1-6, 2241775, 18271999.
7. Newman JT, Stahel PF, Smith WR, Resende GV, Hak DJ, Morgan SJ. A new minimally invasive technique for large volume bone graft harvest for treatment of fracture nonunions. Orthopedics 2008, 31(3):257-261. 10.3928/01477447-20080301-29, 18351046.
8. Dimitriou R, Mataliotakis GI, Angoules AG, Kanakaris NK, Giannoudis PV. Complications following autologous bone graft harvesting from the iliac crest and using the RIA: a systematic review. Injury 2011, 42(Suppl. 2):S3-S15.
9. Herscovici D, Scaduto JM. Use of reamer-irrigator-aspirator technique to obtain autograft for ankle and hindfoot arthrodesis. J Bone Joint Surg Br 2012, 94(1):75-79.
10. Sen MK, Micalu T. Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions?. Injury 2007, 38(Suppl. 1):S75-S80.
11. Kanakaris NK, Paliobeis C, Nlanidakis N, Giannoudis PV. Biological enhancement of tibial diaphyseal aseptic non-unions: the efficacy of autologous bone grafting, BMPs and reaming by-products. Injury 2007, 38(Suppl 2):S65-S75.
12. Giannoudis PV, Dinopoulos HT. BMPs: options, indications, and effectiveness. J Orthop Trauma 2010, 24(Suppl 1):S9-S16.
13. Garrison KR, Shemilt I, Donell S, Ryder JJ, Mugford M, Harvey I, Song F, Alt V. Bone morphogenetic protein (BMP) for fracture healing in adults. Cochrane Database Syst Rev 2010, 6. CD006950.
14. Burks MV, Nair L. Long-term effects of bone morphogenetic protein-based treatments in humans. J Long Term Eff Med Implants 2010, 20(4):277-293. 10.1615/JLongTermEffMedImplants.v20.i4.30, 21488821.
15. Argintar E, Edwards S, Delahay J. Bone morphogenetic proteins in orthopaedic trauma surgery. Injury 2011, 42(8):730-734. 10.1016/j.injury.2010.11.016, 21145058.
16. Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 2011, 11(6):471-491. 10.1016/j.spinee.2011.04.023, 21729796.
17. Carragee EJGAJ, Weiner BK, Rothman DJ, Bono CM. A challenge to integrity in spine publications: years of living dangerously with the promotion of bone growth factors. Spine J 2011, 11(6):463-468. 10.1016/j.spinee.2011.06.001, 21729794.
18. Mroz TE, Wang JC, Hashimoto R, Norvell DC. Complications related to osteobiologics use in spine surgery: a systematic review. Spine (Phila Pa 1976) 2010, 35(9):S86-S104.
19. Frolke JP, Patka P. Definition and classification of fracture non-unions. Injury 2007, 38(Suppl 2):S19-S22.
20. Corrales LA, Morshed S, Bhandari M, Miclau T. Variability in the assessment of fracture-healing in orthopaedic trauma studies. J Bone Joint Surg Am 2008, 90(9):1862-1868. 10.2106/JBJS.G.01580, 2663323, 18762645.
21. Morshed S, Corrales L, Genant H, Miclau T. Outcome assessment in clinical trials of fracture-healing. J Bone Joint Surg Am 2008, 90(Suppl 1):62-67.
22. Giannoudis PV, Dinopoulos HT. Autologous bone graft: when shall we add growth factors?. Foot Ankle Clin 2010, 15(4):597-609. 10.1016/j.fcl.2010.09.005, 21056859.
23. Marsell R, Einhorn TA. Emerging bone healing therapies. J Orthop Trauma 2010, 24(Suppl 1):S4-S8.
24. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Borner MG, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der Velde D, Hardy P, Holt M, Josten C, Ketterl RL, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002, 84-A(12):2123-2134.
25. Jones AL, Bucholz RW, Bosse MJ, Mirza SK, Lyon TR, Webb LX, Pollak AN, Golden JD, Valentin-Opran A. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects: a randomized, controlled trial. J Bone Joint Surg Am 2006, 88(7):1431-1441. 10.2106/JBJS.E.00381, 16818967.
26. Aro HT, Govender S, Patel AD, Hernigou P, Perera De Gregorio A, Popescu GI, Golden JD, Christensen J, Valentin A. Recombinant human bone morphogenetic protein-2: a randomized trial in open tibial fractures treated with reamed nail fixation. J Bone Joint Surg Am 2011, 93(9):801-808. 10.2106/JBJS.I.01763, 21454742.
27. Tressler MA, Richards JE, Sofianos D, Comrie FK, Kregor PJ, Obremskey WT. Bone morphogenetic protein-2 compared to autologous iliac crest bone graft in the treatment of long bone nonunion. Orthopedics 2011, 34(12):e877-e884.
28. Weiss KR, Cooper GM, Jadlowiec JA, McGough RL, Huard J. VEGF and BMP expression in mouse osteosarcoma cells. Clin Orthop Relat Res 2006, 450:111-117.
29. Yoshikawa H, Nakase T, Myoui A, Ueda T. Bone morphogenetic proteins in bone tumors. J Orthop Sci 2004, 9(3):334-340. 10.1007/s00776-004-0764-9, 15168194.
30. Krause F, Younger A, Weber M. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. J Bone Joint Surg Am 2008, 90(5):1168-1169.
31. Ritting AW, Weber EW, Lee MC. Exaggerated inflammatory response and bony resorption from BMP-2 use in a pediatric forearm nonunion. J Hand Surg [Am] 2012, 37(2):316-321.
32. Kinney RC, Ziran BH, Hirshorn K, Schlatterer D, Ganey T. Demineralized bone matrix for fracture healing: fact or fiction?. J Orthop Trauma 2010, 24(Suppl 1):S52-S55.
33. Takikawa S, Bauer TW, Kambic H, Togawa D. Comparative evaluation of the osteoinductivity of two formulations of human demineralized bone matrix. J Biomed Mater Res A 2003, 65(1):37-42.
34. Boyce T, Edwards J, Scarborough N. Allograft bone: the influence of processing on safety and performance. Orthop Clin North Am 1999, 30(4):571-581. 10.1016/S0030-5898(05)70110-3, 10471762.
35. Bae HW, Zhao L, Kanim LE, Wong P, Delamarter RB, Dawson EG. Intervariability and intravariability of bone morphogenetic proteins in commercially available demineralized bone matrix products. Spine (Phila Pa 1976) 2006, 31(12):1299-1306. discussion 1307-1298.
36. Bae H, Zhao L, Zhu D, Kanim LE, Wang JC, Delamarter RB. Variability across ten production lots of a single demineralized bone matrix product. J Bone Joint Surg Am 2010, 92(2):427-435. 10.2106/JBJS.H.01400, 20124070.
37. Pape HC, Evans A, Kobbe P. Autologous bone graft: properties and techniques. J Orthop Trauma 2010, 24(Suppl 1):S36-S40.
38. Marino JT, Ziran BH. Use of solid and cancellous autologous bone graft for fractures and nonunions. Orthop Clin North Am 2010, 41(1):15-26. 10.1016/j.ocl.2009.08.003, 19931049.
39. Ahlmann E, Patzakis M, Roidis N, Shepherd L, Holtom P. Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes. J Bone Joint Surg Am 2002, 84-A(5):716-720.
40. DeOrio JK, Farber DC. Morbidity associated with anterior iliac crest bone grafting in foot and ankle surgery. Foot Ankle Int 2005, 26(2):147-151.
41. Belthur MV, Conway JD, Jindal G, Ranade A, Herzenberg JE. Bone graft harvest using a new intramedullary system. Clin Orthop Relat Res 2008, 466(12):2973-2980. 10.1007/s11999-008-0538-3, 2628246, 18841433.
42. Conway JD. Autograft and nonunions: morbidity with intramedullary bone graft versus iliac crest bone graft. Orthop Clin North Am 2010, 41(1):75-84. 10.1016/j.ocl.2009.07.006, 19931055.
43. Stannard JP, Sathy AK, Moeinpour F, Stewart RL, Volgas DA. Quantitative analysis of growth factors from a second filter using the Reamer-Irrigator-Aspirator system: description of a novel technique. Orthop Clin North Am 2010, 41(1):95-98. 10.1016/j.ocl.2009.07.002, 19931057.
44. Hak DJ, Pittman JL. Biological rationale for the intramedullary canal as a source of autograft material. Orthop Clin North Am 2010, 41(1):57-61. 10.1016/j.ocl.2009.07.005, 19931053.